These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24859150)

  • 21. Computational methods for studying G protein-coupled receptors (GPCRs).
    Kaczor AA; Rutkowska E; Bartuzi D; Targowska-Duda KM; Matosiuk D; Selent J
    Methods Cell Biol; 2016; 132():359-99. PubMed ID: 26928552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists.
    Kolb P; Phan K; Gao ZG; Marko AC; Sali A; Jacobson KA
    PLoS One; 2012; 7(11):e49910. PubMed ID: 23185482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors.
    Kim Y; Hechler B; Gao ZG; Gachet C; Jacobson KA
    Bioconjug Chem; 2009 Oct; 20(10):1888-98. PubMed ID: 19785401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.
    van der Horst E; Peironcely JE; Ijzerman AP; Beukers MW; Lane JR; van Vlijmen HW; Emmerich MT; Okuno Y; Bender A
    BMC Bioinformatics; 2010 Jun; 11():316. PubMed ID: 20537162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Receptor-ligand docking simulation for membrane proteins].
    Hirokawa T
    Yakugaku Zasshi; 2007 Jan; 127(1):123-31. PubMed ID: 17202792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Volpini R; Cristalli G
    Curr Med Chem; 2011; 18(10):1444-63. PubMed ID: 21428896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A
    Yu J; Mannes P; Jung YH; Ciancetta A; Bitant A; Lieberman DI; Khaznadar S; Auchampach JA; Gao ZG; Jacobson KA
    Medchemcomm; 2018 Nov; 9(11):1920-1932. PubMed ID: 30568760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs.
    Levit A; Yarnitzky T; Wiener A; Meidan R; Niv MY
    PLoS One; 2011; 6(11):e27990. PubMed ID: 22132188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Metadynamics-Based Protocol for the Determination of GPCR-Ligand Binding Modes.
    Söldner CA; Horn AHC; Sticht H
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding Ligand Binding Selectivity in a Prototypical GPCR Family.
    Mattedi G; Deflorian F; Mason JS; de Graaf C; Gervasio FL
    J Chem Inf Model; 2019 Jun; 59(6):2830-2836. PubMed ID: 31125224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.
    Jacobson KA; Costanzi S
    Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
    Margiotta E; Deganutti G; Moro S
    J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG; Poerio E
    BMC Struct Biol; 2015 Sep; 15():16. PubMed ID: 26346819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents.
    Zafar A; Sari S; Leung E; Pilkington LI; van Rensburg M; Barker D; Reynisson J
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29258235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors.
    Lakkaraju SK; Yu W; Raman EP; Hershfeld AV; Fang L; Deshpande DA; MacKerell AD
    J Chem Inf Model; 2015 Mar; 55(3):700-8. PubMed ID: 25692383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M; Hirokawa T
    J Chem Inf Model; 2014 Nov; 54(11):3153-61. PubMed ID: 25350693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
    Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
    J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova.
    Ciancetta A; Cuzzolin A; Deganutti G; Sturlese M; Salmaso V; Cristiani A; Sabbadin D; Moro S
    Mol Inform; 2016 Sep; 35(8-9):440-8. PubMed ID: 27546048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.